Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech’s Cancer Product Line Expands, As Do Its Post-Market Manufacturing Obligations

Mar 01 2013

• By Michael McCaughan

Related Content

Breaking Down the First “Breakthrough”

Jan 09 2013

FDA “Flexibility” Presages Good Climate in 2012 for Approval Decisions, Shortage Situations

Jan 15 2012

Genentech’s <em>Perjeta</em> Clears FDA Despite Unresolved Manufacturing Issues

Jun 18 2012

How to Withdraw a Drug: FDA’s Final Decision on Avastin

Nov 20 2011

Roche and FDA in Oncology: Fighting in Public, Collaboarting in Private

Nov 01 2011

Related Companies

Roche Holding AG

Genentech, Inc.

ImmunoGen, Inc.

Additional Topics

Drug Approval Standards Quality BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window